2018 Global Artemisinin Derivatives Industry Report - History, Present and Future

November 2018 | 140 pages | ID: 29C7200FFC2PEN
Prof Research

Abstracts

The global market size of Artemisinin Derivatives is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:

• North America
• South America
• Asia & Pacific
• Europe
• MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Artemisinin Derivatives as well as some small players. The compnaies include:

Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource, Botanical Extracts EPZ Lt et al.

The information for each competitor includes:

• Company Profile
• Main Business Information
• SWOT Analysis
• Sales, Revenue, Price and Gross Margin
• Market Share

We also can offer customized report to fulfill special requirements of our clients.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Artemisinin Derivatives Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Artemisinin Derivatives by Region
8.2 Import of Artemisinin Derivatives by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT ARTEMISININ DERIVATIVES MARKET IN NORTH AMERICA (2013-2018)

9.1 Artemisinin Derivatives Supply
9.2 Artemisinin Derivatives Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT ARTEMISININ DERIVATIVES MARKET IN SOUTH AMERICA (2013-2018)

10.1 Artemisinin Derivatives Supply
10.2 Artemisinin Derivatives Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT ARTEMISININ DERIVATIVES MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Artemisinin Derivatives Supply
11.2 Artemisinin Derivatives Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT ARTEMISININ DERIVATIVES MARKET IN EUROPE (2013-2018)

12.1 Artemisinin Derivatives Supply
12.2 Artemisinin Derivatives Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT ARTEMISININ DERIVATIVES MARKET IN MEA (2013-2018)

13.1 Artemisinin Derivatives Supply
13.2 Artemisinin Derivatives Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL ARTEMISININ DERIVATIVES MARKET (2013-2018)

14.1 Artemisinin Derivatives Supply
14.2 Artemisinin Derivatives Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL ARTEMISININ DERIVATIVES MARKET FORECAST (2019-2023)

15.1 Artemisinin Derivatives Supply Forecast
15.2 Artemisinin Derivatives Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(SANOFI, KPC PHARMACEUTICALS, GUANGXI XIANCAOTANG PHARMACEUTICAL, GUILIN PHARMACEUTICAL, KERUI NANHAI PHARMACEUTICAL, SHANGHAI NATURAL BIO-ENGINEERING CO, NOVANAT BIORESOURCE, BOTANICAL EXTRACTS EPZ LT ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Artemisinin Derivatives Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Artemisinin Derivatives Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Artemisinin Derivatives Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Artemisinin Derivatives Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Artemisinin Derivatives Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Artemisinin Derivatives Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Artemisinin Derivatives Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2013-2018)

Tables & Figures

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Artemisinin Derivatives Report
Table Primary Sources of Artemisinin Derivatives Report
Table Secondary Sources of Artemisinin Derivatives Report
Table Major Assumptions of Artemisinin Derivatives Report
Figure Artemisinin Derivatives Picture
Table Artemisinin Derivatives Classification
Table Artemisinin Derivatives Applications List
Table Drivers of Artemisinin Derivatives Market
Table Restraints of Artemisinin Derivatives Market
Table Opportunities of Artemisinin Derivatives Market
Table Threats of Artemisinin Derivatives Market
Table Key Raw Material of Artemisinin Derivatives and Its Suppliers
Table Key Technologies of Artemisinin Derivatives
Table Cost Structure of Artemisinin Derivatives
Table Market Channel of Artemisinin Derivatives
Table Artemisinin Derivatives Application and Key End Users List
Table Latest News of Artemisinin Derivatives Industry
Table Recently Merger and Acquisition List of Artemisinin Derivatives Industry
Table Recently Planned/Future Project List of Artemisinin Derivatives Industry
Table Policy Dynamics Update of Artemisinin Derivatives Industry
Table 2013-2023 Export of Artemisinin Derivatives by Region
Table 2013-2023 Import of Artemisinin Derivatives by Region
Table 2013-2023 Balance of Trade of Artemisinin Derivatives
Figure 2013 2018 and 2023 Global Trade Map of Artemisinin Derivatives
Table 2013-2018 North America Supply of Artemisinin Derivatives
Figure 2013-2018 North America Artemisinin Derivatives Supply and GAGR
Table 2013-2018 North America Artemisinin Derivatives Downstream Demand List
Figure 2013-2018 North America Artemisinin Derivatives Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Artemisinin Derivatives Demand by Type
Figure 2013-2018 North America Artemisinin Derivatives Price
Table 2013-2018 Key Countries Supply of Artemisinin Derivatives in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Artemisinin Derivatives in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Artemisinin Derivatives
Figure 2013-2018 South America Artemisinin Derivatives Supply and GAGR
Table 2013-2018 South America Artemisinin Derivatives Downstream Demand List
Figure 2013-2018 South America Artemisinin Derivatives Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Artemisinin Derivatives Demand by Type
Figure 2013-2018 South America Artemisinin Derivatives Price
Table 2013-2018 Key Countries Supply of Artemisinin Derivatives in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Artemisinin Derivatives in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Artemisinin Derivatives
Figure 2013-2018 Asia & Pacific Artemisinin Derivatives Supply and GAGR
Table 2013-2018 Asia & Pacific Artemisinin Derivatives Downstream Demand List
Figure 2013-2018 Asia & Pacific Artemisinin Derivatives Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Artemisinin Derivatives Demand by Type
Figure 2013-2018 Asia & Pacific Artemisinin Derivatives Price
Table 2013-2018 Key Countries Supply of Artemisinin Derivatives in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Artemisinin Derivatives in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Artemisinin Derivatives
Figure 2013-2018 Europe Artemisinin Derivatives Supply and GAGR
Table 2013-2018 Europe Artemisinin Derivatives Downstream Demand List
Figure 2013-2018 Europe Artemisinin Derivatives Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Artemisinin Derivatives Demand by Type
Figure 2013-2018 Europe Artemisinin Derivatives Price
Table 2013-2018 Key Countries Supply of Artemisinin Derivatives in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Artemisinin Derivatives in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Artemisinin Derivatives
Figure 2013-2018 MEA Artemisinin Derivatives Supply and GAGR
Table 2013-2018 MEA Artemisinin Derivatives Downstream Demand List
Figure 2013-2018 MEA Artemisinin Derivatives Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Artemisinin Derivatives Demand by Type
Figure 2013-2018 MEA Artemisinin Derivatives Price
Table 2013-2018 Key Countries Supply of Artemisinin Derivatives in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Artemisinin Derivatives in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Artemisinin Derivatives by Region
Figure 2013-2018 Global Supply and CAGR of Artemisinin Derivatives by Region
Table 2013-2018 Global Artemisinin Derivatives Downstream Demand List by Region
Figure 2013-2018 Global Artemisinin Derivatives Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Artemisinin Derivatives Type-wise Demand by Region
Figure 2013-2018 Global Artemisinin Derivatives Price
Table Main Business and Artemisinin Derivatives Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Artemisinin Derivatives Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Artemisinin Derivatives Sales Revenue and Growth Rate
Figure 2013-2018 Company A Artemisinin Derivatives Market Share
Table Main Business and Artemisinin Derivatives Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Artemisinin Derivatives Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Artemisinin Derivatives Sales Revenue and Growth Rate
Figure 2013-2018 Company B Artemisinin Derivatives Market Share
Table Main Business and Artemisinin Derivatives Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Artemisinin Derivatives Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Artemisinin Derivatives Sales Revenue and Growth Rate
Figure 2013-2018 Company C Artemisinin Derivatives Market Share
Table Main Business and Artemisinin Derivatives Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Artemisinin Derivatives Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Artemisinin Derivatives Sales Revenue and Growth Rate
Figure 2013-2018 Company D Artemisinin Derivatives Market Share
Table Main Business and Artemisinin Derivatives Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Artemisinin Derivatives Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Artemisinin Derivatives Sales Revenue and Growth Rate
Figure 2013-2018 Company E Artemisinin Derivatives Market Share
Table Main Business and Artemisinin Derivatives Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Artemisinin Derivatives Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Artemisinin Derivatives Sales Revenue and Growth Rate
Figure 2013-2018 Company F Artemisinin Derivatives Market Share
Table Main Business and Artemisinin Derivatives Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Artemisinin Derivatives Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Artemisinin Derivatives Sales Revenue and Growth Rate
Figure 2013-2018 Company G Artemisinin Derivatives Market Share